Among these genes, ROCK2 has been widely studied in arteriosclerosis and vascular smooth muscle cells [10–12], indicating that in ASO, ROCK2 may be involved in the microRNA-30a-3p functional process and may be a microRNA-30a-3p direct target gene. The gene discussed is ROCK2; the disease is arteriosclerosis.